Showing results (31-40 of 468) with videos related to
Sort By:
Pageof 47
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Adolescent and young adult colorectal cancerJoleen M Hubbard, Axel GrotheyCancer Journal (Sudbury, Mass.)|June 25, 2016
Chemotherapy MaintenancePashtoon Murtaza Kasi, Axel GrotheyDrugs|June 3, 2017
Napabucasin: An Update on the First-in-Class Cancer Stemness InhibitorJoleen M Hubbard, Axel GrotheyBiologics : Targets & Therapy|August 27, 2009
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumabGeorge P Kim, Axel GrotheyOncology (Williston Park, N.Y.)|June 1, 2007
Optimizing palliative treatment of metastatic colorectal cancer in the era of biologic therapyAxel Grothey, John L MarshallClinical Colorectal Cancer|October 10, 2006
Do all patients with metastatic colorectal cancer need chemotherapy until disease progression?Tara Beers Gibson, Axel GrotheyDrugs|May 14, 2018
Chemotherapy-Induced Neutropenia as a Prognostic and Predictive Marker of Outcomes in Solid-Tumor PatientsPashtoon Murtaza Kasi, Axel GrotheyJournal of the National Comprehensive Cancer Network : JNCCN|May 23, 2018
Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal CancerAxel Grothey, Alan P VenookClinical Colorectal Cancer|December 13, 2005
Enhancing oxaliplatin-based regimens in colorectal cancer by inhibiting the epidermal growth factor receptor pathwayGeorge P Kim, Axel GrotheyClinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal CancerMichaela S Banck, Axel GrotheyPageof 47